BioMarin Pharmaceuticals
BMRN
BMRN
553 hedge funds and large institutions have $15.5B invested in BioMarin Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 67 funds opening new positions, 196 increasing their positions, 191 reducing their positions, and 59 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
553
Holders Change
+5
Holders Change %
+0.91%
% of All Funds
8.72%
Holding in Top 10
11
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.17%
New
67
Increased
196
Reduced
191
Closed
59
Calls
$148M
Puts
$158M
Net Calls
-$9.91M
Net Calls Change
-$124M
Top Buyers
Top Sellers
| 1 |
Invesco
Atlanta,
Georgia
|
$85.3M |
| 2 |
Amundi
Paris,
France
|
$37M |
| 3 |
BlackRock
New York
|
$1.21B |
| 4 |
Jennison Associates
New York
|
$15.4M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
$586M |
